These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 25525770

  • 21. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
    Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S.
    Lancet; 2013 Jan 12; 381(9861):125-32. PubMed ID: 23158522
    [Abstract] [Full Text] [Related]

  • 22. Subependymal giant cell tumors in tuberous sclerosis complex.
    Goh S, Butler W, Thiele EA.
    Neurology; 2004 Oct 26; 63(8):1457-61. PubMed ID: 15505165
    [Abstract] [Full Text] [Related]

  • 23. Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma.
    Song X, Liu Z, Cappell K, Gregory C, Said Q, Prestifilippo J, Charles H, Hulbert J, Bissler J.
    J Med Econ; 2017 Apr 26; 20(4):388-394. PubMed ID: 27998195
    [Abstract] [Full Text] [Related]

  • 24. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Fogarasi A, De Waele L, Bartalini G, Jozwiak S, Laforgia N, Verhelst H, Petrak B, Pedespan JM, Witt O, Castellana R, Crippa S, Gislimberti G, Gyorsok Z.
    BMC Neurol; 2016 Aug 08; 16():126. PubMed ID: 27502586
    [Abstract] [Full Text] [Related]

  • 25. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report.
    Konakondla S, Jayarao M, Skrade J, Giannini C, Workman MJ, Morgan CJ.
    Clin Neurol Neurosurg; 2016 Nov 08; 150():177-180. PubMed ID: 27690251
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR, Palasamudram S, Zak M, Whitney R, McCoy B, Bouffet E, Taylor M, Shroff M, Bartels U.
    J Neurooncol; 2020 May 08; 147(3):731-736. PubMed ID: 32285309
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME, López-Laso E, Vicente-Rueda J, Camino-León R, Fernández-Ramos JA, Baena-Gómez MA, Peña-Rosa MJ.
    Rev Neurol; 2014 Dec 01; 59(11):497-502. PubMed ID: 25418144
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
    Giordano F, Moscheo C, Lenge M, Biagiotti R, Mari F, Sardi I, Buccoliero AM, Mongardi L, Aronica E, Guerrini R, Genitori L.
    Childs Nerv Syst; 2020 May 01; 36(5):951-960. PubMed ID: 31853898
    [Abstract] [Full Text] [Related]

  • 32. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
    Danassegarane G, Tinois J, Sahler Y, Aouaissia S, Riffaud L.
    Neurochirurgie; 2022 Dec 01; 68(6):627-636. PubMed ID: 35907444
    [Abstract] [Full Text] [Related]

  • 33. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ.
    Pediatr Neurol; 2013 Dec 01; 49(6):439-44. PubMed ID: 24138953
    [Abstract] [Full Text] [Related]

  • 34. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.
    Fohlen M, Ferrand-Sorbets S, Delalande O, Dorfmüller G.
    Childs Nerv Syst; 2018 Aug 01; 34(8):1511-1519. PubMed ID: 29766265
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA.
    J Pediatr; 2014 May 01; 164(5):1195-200. PubMed ID: 24518170
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature].
    Adachi M, Nakamura M, Shinozaki N, Miyazaki T.
    No Shinkei Geka; 2017 May 01; 45(5):397-404. PubMed ID: 28490681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.